Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Daiichi Sankyo
Johnson and Johnson

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,366,722

« Back to Dashboard

Summary for Patent: 5,366,722

Title: Contrast media comprising a non-ionic contrast agent and sodium ions
Abstract:The invention relates to improved contrast media containing non-ionic contrast agents, e.g. non-ionic iodinated X-ray contrast agents, the improvement being achieved by incorporation of sodium at 20-60 mM/l.
Inventor(s): Almen; Torsten (Malmo, SE), B.ANG..ANG.th; Laars (Malmo, SE), Oksendal; Audun (Oslo, NO)
Assignee: Nycomed Imaging AS (Oslo, NO)
Application Number:08/156,998
Patent Claim Types:
see list of patent claims
Composition; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,366,722

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom89 06130.3Mar 17, 1989
PCT Information
PCT FiledMarch 09, 1990PCT Application Number:PCT/EP90/00393
PCT Publication Date:October 04, 1990PCT Publication Number: WO90/11094

International Patent Family for Patent: 5,366,722

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria123954► Subscribe
Australia5185490► Subscribe
Australia638235► Subscribe
Bulgaria60951► Subscribe
Canada2046886► Subscribe
China1045528► Subscribe
China1057703► Subscribe
Czech Republic281381► Subscribe
German Democratic Republic295992► Subscribe
Germany69020208► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: